Gastrointestinal adverse events partially mediated the weight loss effects among patients with obesity who received tirzepatide vs placebo.

Nearly 2 in 3 people without diabetes quit popular weight loss drugs such as Ozempic or Victoza within one year, according to ...

The authors found that individuals on retatrutide (12 mg once-weekly injection) lost 22% of body weight from baseline after 48 weeks. Tirzepatide ... that the greatest loss, aside from retatrutide ...

Physician–scientists at the University of Utah's John A. Moran Eye Center have published an investigatory review of nine patients who experienced vision complications while taking popular semaglutide ...

Enter GetSimpli Oral Tirzepatide, a revolutionary product that promises to transform your approach to weight loss and metabolic health. Unlike traditional weight loss methods that often involve ...

Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...

Tirzepatide, a long-acting agonist of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptors, causes considerable weight loss. New research findings of its effect on ...

Compared to placebo, the data showed that: Tirzepatide resulted in weight loss of nearly 18% after 72 weeks. Semaglutide produced nearly 14% weight loss after 68 weeks. Retatrutide generated ...

Last year, for instance, early trial results of the drug amycretin (developed by Novo Nordisk) suggested that it could provide greater weight loss than semaglutide and tirzepatide. Other drug ...

The FDA is about to make it a lot harder to get cheap weight-loss drugs Jessica DeBenedetto has only been on compounded tirzepatide for a couple of weeks, but she already feels like it's a life ...

Tirzepatide’s dual agonism mechanism allows for 20% average body weight loss in patients. Recent head-to-head trial results demonstrated the superior efficacy of Zepbound over Wegovy ...

On the basis of the clinical trial data, patients on Zepbound (tirzepatide) 5mg weekly lost 16.1 kg (35.5 lb) on average after 72 weeks. For Zepbound’s 10mg weekly dose, the average weight loss ...